12:00 AM
May 15, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Intranasal scopolamine hydrobromide: Update

Nastech Pharmaceutical Co. Inc. (NSTK), Hauppauge, N.Y.
Product: Intranasal scopolamine hydrobromide
Business: Drug delivery
Therapeutic category: Neurotransmission
Target: Parasympathetic neurons
Description: Intranasal scopolamine that inhibits...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >